1.98 Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...

<< vissza

Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...
Dátum: 2024-02-07 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×